** Shares in ALK-Abello ALKb.CO rise 16% after the Danish
pharmaceutical company reported a 41% jump in Q1 operating
profit and raised its full-year sales outlook on Thursday
** It books operating profit of DKK 316 million ($45.46
million) in Q1, up by 41% from a year earlier in local
currencies
** It says the inflow of new patients and improved pricing
boosted its tablet sales in Europe
** The company also raises its outlook, expecting its
revenue to grow by 10-13% in 2024, against 9-12% seen earlier
** The stock touches its highest intra-day price since
August 2022 at DKK 153 per share
($1 = 6.9505 Danish crowns)
(Reporting by Anna Chaberska)
((Anna.chaberska@thomsonreuters.com))